HHS Adds Two Anthrax Drugs to National Stockpile

Anthim from Elusys Therapeutics and Raxibacumab from GlaxoSmithKilne are monoclonal antibody therapeutics. HHS’ BARDA is spending $54.6 million in support of them, the agency announced Nov. 12.

The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response announced it is spending a total of $54.6 million to add two anthrax antitoxin drugs to the Strategic National Stockpile for treating inhalational anthrax. They are Elusys Therapeutics, Inc.'s Anthrim and Raxibacumab from GlaxoSmithKline; both are monoclonal antibody therapeutics.

This was Pine Brook, N.J.-based Elusys' first delivery order under a procurement contract for Anthim (obiltoxaximab) and is a five-year agreement valued at $44.9 million. ASPR’s Biomedical Advanced Research and Development Authority (BARDA) has funded advanced development and procurement of Raxibacumab under Project Bioshield since 2009, and it became the first anthrax antitoxin to be approved by the FDA in 2012. Now, BARDA will provide $9.7 million to ensure a continued supply of Raxibacumab to the stockpile through 2019.

"Anthrax remains a bioterrorist threat, and the actions we are taking today will help protect our nation against that threat," said Robin Robinson, Ph.D., director of BARDA. "By expanding the treatment options available within the SNS, we can help meet the diverse needs of the American people in an anthrax-related emergency."

"Since 2002, Elusys has received over $220 million in grants and contracts from the U.S. Department of Defense, National Institutes of Health, and BARDA, representing a unique — and successful — collaboration with three government agencies from early-stage development through submission and acceptance of our Biologics License Application (BLA), and now procurement. This is a major milestone for our company and a significant realization for the U.S. government," said Elizabeth Posillico, Ph.D., president and CEO of Elusys. "Anthim helps the government diversify its anthrax treatment options and provides an important alternative for protecting military, first responders, and U.S. citizens in an emergency. We are very proud to help protect U.S. citizens against the threat of biowarfare."

According to Elusys, anthrax toxin is composed of three proteins secreted by bacteria. The toxins are not affected by antibiotics that target bacterial cells. Obiltoxaximab binds to the protective antigen component of anthrax toxin, one of the three essential components of anthrax toxin that is necessary for bacterial virulence and ability to harm the host. The toxin-neutralizing activity of obiltoxaximab inhibits entry of anthrax toxin into susceptible cells, averting cell and tissue injury, according to the company.

The secretary of Homeland Security determined anthrax to be a material threat to national security in 2004, and it is labeled a "Category A" biowarfare threat by the US government.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Easy to Use Safety Incident App

    Record incidents on the go with IndustrySafe’s mobile app. Collect data for multiple types of incidents including including near misses, vehicle and environmental incidents, and employee and non-employee injuries; at job sites and remote locations—with or without web access.

  • Complete Online Safety Training Courses

    Deliver state-of-the art, online safety training courses to your organization with IndustrySafe Training Management Software. Generate reports to track training compliance and automatically notify learners of upcoming or overdue classes.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Track Key Safety Performance Indicators

    IndustrySafe’s Dashboard Module allows organizations to easily track safety KPIs and metrics. Gain increased visibility into your business’ operations and safety data.

  • Industry Safe
comments powered by Disqus